Directed evolution of novel binding proteins
AssigneeDyax Corp.
InventorsRobert Charles Ladner, Sonia Kosow Gutterman, Bruce Lindsay Roberts, William Markland, Arthur Charles Ley, Rachel Baribault Kent
Life of this patent
Estimating the term…
Loading patent…
AssigneeDyax Corp.
InventorsRobert Charles Ladner, Sonia Kosow Gutterman, Bruce Lindsay Roberts, William Markland, Arthur Charles Ley, Rachel Baribault Kent
Estimating the term…
In order to obtain a novel binding protein against a chosen target, DNA molecules, each encoding a protein comprising one of a family of similar potential binding domains and a structural signal calling for the display of the protein on the outer surface of a chosen bacterial cell, bacterial spore or phage (genetic package) are introduced into a genetic package. The protein is expressed and the potential binding domain is displayed on the outer surface of the package. The cells or viruses bearing the binding domains which recognize the target molecule are isolated and amplified. The successful binding domains are then characterized. One or more of these successful binding domains is used as a model for the design of a new family of potential binding domains, and the process is repeated until a novel binding domain having a desired affinity for the target molecule is obtained. In one embodiment, the first family of potential binding domains is related to bovine pancreatic trypsin inhibitor, the genetic package is M13 phage, and the protein includes the outer surface transport signal of the M13 gene III protein.
A method of obtaining a nuclecic acid encoding a proteinaceous binding domain that binds a predetermined target material comprising:
A fusion protein consisting of a (a) amino terminal moiety which is a peptide or protein comprising an amino acid sequence foreign to a mature gIII protein of a filamentous phage, and (b) a carboxy terminal carrier protein moiety which comprises essentially all of said mature gIII protein, said fusion protein optionally including (c) a linker between said amino and carboxy terminal moieties, said carrier protein moiety acting, when thr fusion protein is produced in a suitable host cell infected by the phage, to cause the display of the fusion protein or a processed form thereof on the surafce of phage particles produced by the cell.
A fusion protein consisting of (a) a foreign peptide or protein moiety comprising an amino acid sequence foreign to a mature gIII protein of a filamentous phage, and (b) a carrier protein moiety which is a functional portion of said mature gIII protein, said fusion protein optionally including (c) a linker foreign to said gIII protein between said amino and carboxy terminal moieties, said carrier protein corresponding to a carboxy portion of mature gIII protein obtainable by truncating the gIII protein at a domain boundary where a complex of the foreign peptide or protein with a target has a dissociation constant less than or equal to 10.sup.-6 moles/liter.
A method of separating a predetermined target material from a predetermined contaminating material which comprises
A method of separating a predetermined target material from a predetermined contaminating material which comprises
A mehtod of obtaining a nucleic acid encoding a binding protein haing a proteinaceous binding domain that binds a predetermined target material comprising:
Dependencies are inferred from the claim text.